Taj Pharma India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.10 Cr
as on 16-11-2024
- Revenue 3.87%
(FY 2023)
- Profit -1178.88%
(FY 2023)
- Ebitda -243.01%
(FY 2023)
- Net Worth -2356.50%
(FY 2023)
- Total Assets 401.09%
(FY 2023)
About Taj Pharma India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹5.10 Cr.
Ranvir Singh, Priyanka Singh, Abhishek Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U33111MH2011PLC219226
- Company No.
219226
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Taj Pharma India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranvir Singh  | Director | 28-Jun-2011 | Current |
| Priyanka Singh | Additional Director | 27-Jul-2021 | Current |
| Abhishek Singh | Director | 28-Jun-2011 | Current |
| Shantanu Singh | Director | 28-Jun-2011 | Current |
Financial Performance of Taj Pharma India.
Taj Pharma India Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.87% increase. The company also saw a substantial fall in profitability, with a 1178.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 2356.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Taj Pharma India?
In 2023, Taj Pharma India had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Taj Life Sciences Private LimitedActive 16 years 9 daysRanvir Singh, Priyanka Singh and 2 more are mutual person
Taj Pharmaceuticals LimitedActive 20 years 1 monthRanvir Singh and Abhishek Singh are mutual person
Sankara Nethralaya Private LimitedActive 18 years 11 monthsRanvir Singh, Abhishek Singh and 1 more are mutual person
Taj Institute Of Medical Sciences Private LimitedActive 20 years 5 monthsRanvir Singh, Abhishek Singh and 1 more are mutual person
Arcelor Petroleum LimitedActive 15 years 10 monthsRanvir Singh, Priyanka Singh and 1 more are mutual person
- Arcelor Chemicals Private LimitedActive 15 years 11 months
Ranvir Singh and Abhishek Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 22 Sep 2022 | ₹5.10 Cr | Open |
How Many Employees Work at Taj Pharma India?
Unlock and access historical data on people associated with Taj Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Taj Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Taj Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
